122 related articles for article (PubMed ID: 33604618)
1. COPS8 in cutaneous melanoma: an oncogene that accelerates the malignant development of tumor cells and predicts poor prognosis.
Sun L
Biosci Biotechnol Biochem; 2021 Feb; 85(2):242-250. PubMed ID: 33604618
[TBL] [Abstract][Full Text] [Related]
2. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.
Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C
J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173
[TBL] [Abstract][Full Text] [Related]
3. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
4. NAV2 facilitates invasion of cutaneous melanoma cells by targeting SNAI2 through the GSK-3β/β-catenin pathway.
Hu W; Li X; Cheng R; Ke J; Liu Y; Ma M; Cao Y; Liu D
Arch Dermatol Res; 2019 Jul; 311(5):399-410. PubMed ID: 30997569
[TBL] [Abstract][Full Text] [Related]
5. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
[TBL] [Abstract][Full Text] [Related]
8. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H; Liu R; Sun X
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
[TBL] [Abstract][Full Text] [Related]
9. Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
Yan H; Zhu C; Zhang L
J Biochem Mol Toxicol; 2019 Dec; 33(12):e22409. PubMed ID: 31617652
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
11. SSRP1 Worsens Malignant Melanoma Progression by Activating MAPKs Pathway.
Yu Y; Gao Y; Yu Y
Ann Clin Lab Sci; 2021 Nov; 51(6):783-789. PubMed ID: 34921031
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition.
Ding X; Li F; Zhang L
Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
14. YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT.
Kosnopfel C; Sinnberg T; Sauer B; Busch C; Niessner H; Schmitt A; Forchhammer S; Grimmel C; Mertens PR; Hailfinger S; Dunn SE; Garbe C; Schittek B
Mol Cancer Res; 2018 Jul; 16(7):1149-1160. PubMed ID: 29743296
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma.
Liu Y; Chu Z; Li Q; Peng B; Xu S; Lian CG; Geng S
Oncol Rep; 2017 Jan; 37(1):139-146. PubMed ID: 27878257
[TBL] [Abstract][Full Text] [Related]
16. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
17. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
Ren W; Zhu Z; Wu L
J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis.
Ji SM
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():74-80. PubMed ID: 30403179
[TBL] [Abstract][Full Text] [Related]
19. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
